Oxurion to Participate in Upcoming Investor Conferences

June 1, 2022

Leuven, BELGIUM, Boston, MA, US – June 1, 2022 – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that Michael Dillen, Chief Business Officer, will participate in two investor conferences in June.

BIO International 2022
June 13-14, 2022 | San Diego, CA

The JMP Securities Life Sciences Conference
June 15, 2022, 11:30 a.m. ET | New York, NY
A live webcast and 90-day archive will be available in the “Investors” section of the Company’s website.